Longitude Capital Partners IV, LLC

Insider Reports History

Location
Menlo Park, CA
Signature
Longitude Capital Partners IV, LLC By: /s/ Cristiana Blauth Oliveira , Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Longitude Capital Partners IV, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. 10%+ Owner Common Stock 2,567,100 $33,933,468 $13.22 07 Nov 2023 By Longitude Venture Partners IV, L.P.
Vera Therapeutics, Inc. 10%+ Owner Class A Common Stock 1,714,285 $30,857,130 $18.00 06 Feb 2023 Indirect
Lexeo Therapeutics, Inc. 10%+ Owner Series A convertible preferred stock 0 07 Nov 2023 By Longitude Venture Partners IV, L.P.
Lexeo Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 07 Nov 2023 By Longitude Venture Partners IV, L.P.

Insider Reports Filed by Longitude Capital Partners IV, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 07 Nov 2023 5 +$4,999,995 4 10%+ Owner 09 Nov 2023, 20:32
LXEO Lexeo Therapeutics, Inc. 02 Nov 2023 0 $0 3 10%+ Owner 02 Nov 2023, 21:36
VERA Vera Therapeutics, Inc. 06 Feb 2023 1 +$11,999,995 4 10%+ Owner 08 Feb 2023, 18:40
VERA Vera Therapeutics, Inc. 10 Feb 2022 1 +$4,999,995 4 10%+ Owner 05 Apr 2022, 07:24
VERA Vera Therapeutics, Inc. 18 May 2021 3 +$9,999,990 4 10%+ Owner 18 May 2021, 20:20
VERA Vera Therapeutics, Inc. 13 May 2021 0 $0 3 10%+ Owner 13 May 2021, 19:27